GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tilray Brands Inc (FRA:2HQ) » Definitions » Effective Interest Rate on Debt %

Tilray Brands (FRA:2HQ) Effective Interest Rate on Debt % : 6.75% (As of Feb. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Tilray Brands Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Tilray Brands's annualized positive value of Interest Expense for the quarter that ended in Feb. 2024 was €31.6 Mil. Tilray Brands's average total debt for the quarter that ended in Feb. 2024 was €467.8 Mil. Therefore, Tilray Brands's annualized Effective Interest Rate on Debt % for the quarter that ended in Feb. 2024 was 6.75%.


Tilray Brands Effective Interest Rate on Debt % Historical Data

The historical data trend for Tilray Brands's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tilray Brands Effective Interest Rate on Debt % Chart

Tilray Brands Annual Data
Trend Aug14 May15 May16 May17 May18 May19 May20 May21 May22 May23
Effective Interest Rate on Debt %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.06 7.84 4.85 5.51 7.57

Tilray Brands Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Effective Interest Rate on Debt % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.67 25.30 6.81 6.34 6.75

Competitive Comparison of Tilray Brands's Effective Interest Rate on Debt %

For the Drug Manufacturers - Specialty & Generic subindustry, Tilray Brands's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tilray Brands's Effective Interest Rate on Debt % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tilray Brands's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Tilray Brands's Effective Interest Rate on Debt % falls into.



Tilray Brands Effective Interest Rate on Debt % Calculation

Tilray Brands's annualized Effective Interest Rate on Debt % for the fiscal year that ended in May. 2023 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (A: May. 2022 )+Total Debt  (A: May. 2023 ))/ count )
=-1  *  -42.883/( (590.121+542.92)/ 2 )
=-1  *  -42.883/566.5205
=7.57 %

where

Total Debt  (A: May. 2022 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=502.475 + 87.646
=590.121

Total Debt  (A: May. 2023 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=336.599 + 206.321
=542.92

Tilray Brands's annualized Effective Interest Rate on Debt % for the quarter that ended in Feb. 2024 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (Q: Nov. 2023 )+Total Debt  (Q: Feb. 2024 ))/ count )
=-1  *  -31.58/( (489.147+446.46)/ 2 )
=-1  *  -31.58/467.8035
=6.75 %

where

Total Debt  (Q: Nov. 2023 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=335.194 + 153.953
=489.147

Total Debt  (Q: Feb. 2024 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=338.784 + 107.676
=446.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is four times the quarterly (Feb. 2024) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.


Tilray Brands  (FRA:2HQ) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.


Tilray Brands Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of Tilray Brands's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.


Tilray Brands (FRA:2HQ) Business Description

Industry
Traded in Other Exchanges
Address
265 Talbot Street West, Leamington, ON, CAN, N8H 5L4
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products and alcohol.

Tilray Brands (FRA:2HQ) Headlines

No Headlines